RESTORIL

This brand name is authorized in Canada, United States

Active ingredients

The drug RESTORIL contains one active pharmaceutical ingredient (API):

1 Temazepam
UNII CHB1QD2QSS - TEMAZEPAM

Temazepam is a benzodiazepine with hypnotic and sedative effects as well as anxiolytic activity. Temazepam effects are likely to be due to potentiation of gamma-aminobutyric acid (GABA), although other neurotransmitters may also be affected.

Read about Temazepam

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
RESTORIL Capsule FDA, National Drug Code (US) MPI, US: SPL/Old

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
N05CD07 Temazepam N Nervous system → N05 Psycholeptics → N05C Hypnotics and sedatives → N05CD Benzodiazepine derivatives
Discover more medicines within N05CD07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: CA Health Products and Food Branch Identifier(s): 00604453, 00604461
Country: US FDA, National Drug Code Identifier(s): 0406-9914, 0406-9915, 0406-9916, 0406-9917

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.